Meyka Pro banner
Adherium Limited

Adherium Limited Fundamental Analysis (ASX: ADR.AX)

ADR.AX●ASX
HealthcareMedical - Devices
$0.06
$0.006(8.96%)
Australian Market opens in 53h 1m

Adherium Limited Fundamental Analysis (ASX: ADR.AX)

Adherium Limited (ASX: ADR.AX) shows moderate financial fundamentals with a PE ratio of -0.15, profit margin of -6.74%, and ROE of 13.63%. The company generates $0.0B in annual revenue with weak year-over-year growth of -2.82%.

Key Strengths

Cash Position42.53%
PEG Ratio-0.00

Areas of Concern

Operating Margin-6.84%
Current Ratio0.77
We analyze ADR.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -452.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-452.8/100

We analyze ADR.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

ADR.AX struggles to generate sufficient returns from assets.

ROA > 10%
-3.10%

Valuation Score

Excellent

ADR.AX trades at attractive valuation levels.

PE < 25
-0.15
PEG Ratio < 2
-0.00

Growth Score

Moderate

ADR.AX shows steady but slowing expansion.

Revenue Growth > 5%
-2.82%
EPS Growth > 10%
48.73%

Financial Health Score

Moderate

ADR.AX shows balanced financial health with some risks.

Debt/Equity < 1
-1.86
Current Ratio > 1
0.77

Profitability Score

Weak

ADR.AX struggles to sustain strong margins.

ROE > 15%
13.63%
Net Margin ≥ 15%
-6.74%
Positive Free Cash Flow
No

Key Financial Metrics

Is ADR.AX Expensive or Cheap?

P/E Ratio

ADR.AX trades at -0.15 times earnings. This suggests potential undervaluation.

-0.15

PEG Ratio

When adjusting for growth, ADR.AX's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Adherium Limited at -2.60 times its book value. This may indicate undervaluation.

-2.60

EV/EBITDA

Enterprise value stands at -0.01 times EBITDA. This is generally considered low.

-0.01

How Well Does ADR.AX Make Money?

Net Profit Margin

For every $100 in sales, Adherium Limited keeps $-6.74 as profit after all expenses.

-6.74%

Operating Margin

Core operations generate -6.84 in profit for every $100 in revenue, before interest and taxes.

-6.84%

ROE

Management delivers $13.63 in profit for every $100 of shareholder equity.

13.63%

ROA

Adherium Limited generates $-3.10 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.10%

Following the Money - Real Cash Generation

Operating Cash Flow

Adherium Limited generates limited operating cash flow of $-5.21M, signaling weaker underlying cash strength.

$-5.21M

Free Cash Flow

Adherium Limited generates weak or negative free cash flow of $-5.22M, restricting financial flexibility.

$-5.22M

FCF Per Share

Each share generates $-0.27 in free cash annually.

$-0.27

FCF Yield

ADR.AX converts -12.65% of its market value into free cash.

-12.65%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.15

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

-2.60

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.56

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-1.86

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.77

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

13.63

vs 25 benchmark

ROA

Return on assets percentage

-3.10

vs 25 benchmark

ROCE

Return on capital employed

11.31

vs 25 benchmark

How ADR.AX Stacks Against Its Sector Peers

MetricADR.AX ValueSector AveragePerformance
P/E Ratio-0.1531.14 Better (Cheaper)
ROE1363.47%554.00% Excellent
Net Margin-674.21%5163.00% Weak
Debt/Equity-1.860.01 Strong (Low Leverage)
Current Ratio0.775.75 Weak Liquidity
ROA-310.29%-245.00% (disorted) Weak

ADR.AX outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Adherium Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-99.14%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

97.40%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

96.81%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ